P18SMI-21
P18SMI-21 is a novel INK4C inhibitor that specifically blocks the biological activity of p18 protein. p18SMI-21 exerts its anti-gastric acid effect through direct contact, and the intensity of this effect varies with the dose. p18SMI-21 can significantly reduce the proteolytic activity of pepsin under certain conditions. The inhibitory effect of p18SMI-21 is best achieved in direct contact with the substrate. If it contacts the substrate first, the inhibitory effect will be lost[1].
Product Specifications
CAS Number
20535-76-6
UNSPSC
12352005
Hazard Statement
H315-H319-H320
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/p18smi-21.html
Smiles
CC(NC1=CC=C(C=C1)S(=O)(NCCO)=O)=O
Molecular Formula
C10H14N2O4S
Molecular Weight
258.29
Precautions
P264-P280-P302+P352-P305+P351+P338-P362
References & Citations
[1][Biochemical studies on camomile components/III. In vitro studies about the antipeptic activity of (--) -alpha-bisabolol (author's transl) ]
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Stefin B (CSTB) (NM_000100) Human Over-expression Lysate
